Opportunity Overview
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient tiotropium bromide exclusively in the Dafo inhalation solution, ATC R03BB04, valid from 01.11.25 to 31.10.27
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Health |
|---|---|
| Country | Germany |
| Category | Pharmaceuticals |
| Published | September 16, 2025 |
| Procurement stage | Active solicitation |
| Closed | August 29, 2027 |
| Status | Closed — no longer accepting responses |
| Translation | Translated from German by GlobalGov’s translation pipeline |
| Official source | View original notice |
| Last verified | August 10, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in Germany
Germany – Pharmaceutical products – OpenHouse-Verfahren Diverse Arzneimittelwirkstoffe ab 01.10.2025
See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free Germany Pharmaceuticals intelligence report in your inbox
A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.